2009, Number 3
<< Back Next >>
Med Cutan Iber Lat Am 2009; 37 (3)
Elastoris perforans serpiginosa in a patient with Wilson’s disease treated with penicillamine
Almazán-Fernández FM, Abad-Romero J, Hernández-Gil SJ, Naranjo-Sintes R
Language: Spanish
References: 10
Page: 151-153
PDF size: 171.77 Kb.
ABSTRACT
Elastosis Perforans Serpiginosa belongs to perforating diseases of the skin. It is a rare condition that appears in early ages, childhood or early adult age. Almost half of the cases are related to different genetic alterations or prolonged treatments with penicillamine. The lesions are queratotic papules of 2-5mm with serpiginous or annular pattern, and the neck and the flexures are the most frequent locations. The principal anatomopathologic characteristics are hiperplasic and transepidermal elimination of elastic fiber. We show a patient with 48 years old, with Wilson’s disease in treatment with D-penicillamine, who consulted by annular repetitive lesions and spontaneous resolution.
REFERENCES
Patterson JW. The perforating disorders. J Am Acad Dermatol 1984; 10: 561-81.
Santamaría González V, Cervantes Acevedo AM, Barrios Ganem E. Dermatosis con eliminación transepidérmica clásicas. Rev Cent Dermatol Pascua 2002; 11: 40-8.
Bécuwe C, Dalle S, Ronger-Savlé S, Skowron F, Balme B, Kanitakis J, Thomas L. Elastosis perforans serpiginosa associated with pseudo- pseudoxanthoma elasticum during treatment of Wilson’s disease with penicillamine. Dermatology 2005; 210: 60-3.
Iozumi K, Nakagawa H, Tamaki K. Penicillamine- induced degenerative dermatoses: report of a case and brief review of such dermatoses. J Dermatol 1997; 24: 458- 65.
Rosen LB, Muellenhoff M, Tran TT, Muhart M. Elastosis perforans serpiginosa secondary to D-penicillamine therapy with coexisting cutis laxa. Cutis 2005; 76: 49-53.
Langeveld-Wildschut EG, Toonstra J, Van Vloten WA, Beemer FA. Familial elastosis perforans serpiginosa. Arch Dermatol 1993; 129: 205-7.
Ríos-Buceta L, Amigo-Echenaugisía A, Sols- Candelas M, Fraga-Fernández J, Fernández- Herrera J. Elastosis perforans serpiginosa with simultaneous onset in two sisters. Int J Dermatol 1993; 32: 879-81.
Fujimoto N, Akagi A, Tajima S, Ishibashi A, Nomura K, Matsushita A, et al. Expression of the 67-kDa elastin receptor in perforating skin disorders. Br J Dermatol 2002; 146: 74- 9.
Kelly SC, Purcell SM. Imiquimod therapy for elastosis perforans serpiginosa. Arch Dermatol 2006; 142: 829-30.
Kaufman AJ. Treatment of elastosis perforans serpiginosa with the flashlamp pulsed dye laser. Dermatol Surg 2000; 26: 1060-2.